-
公开(公告)号:US07833991B2
公开(公告)日:2010-11-16
申请号:US11704860
申请日:2007-02-09
申请人: Toru Yamazaki , Shigeyuki Kikumoto , Masahiro Ono , Atsushi Saitou , Haruka Takahashi , Sei Kumakura , Kunitaka Hirose , Mikiro Yanaka , Yoshiyuki Takemura , Shigeru Suzuki , Ryo Matsui
发明人: Toru Yamazaki , Shigeyuki Kikumoto , Masahiro Ono , Atsushi Saitou , Haruka Takahashi , Sei Kumakura , Kunitaka Hirose , Mikiro Yanaka , Yoshiyuki Takemura , Shigeru Suzuki , Ryo Matsui
IPC分类号: C07D403/02 , A01N43/50
CPC分类号: C07D233/64 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D417/12 , C07D417/14
摘要: It is intended to provide novel amine compounds which are efficacious against diseases such as infection with HIV virus, rheumatism and cancer metastasis. Namely, amine compounds represented by the following general formula (1): In a typical case, A1 and A2 represent each an optionally substituted monocyclic or polycyclic aromatic heterocycle; W represents cyclic C3-10 alkylene, an optionally substituted monocyclic or polycyclic aromatic heterocycle, a monocyclic or polycyclic aromatic ring or a partly saturated polycyclic aromatic ring; X represents O, CH2, C(═O) or NR11; and D is a group represented by the following general formula (4) or (6). In the formula (6), Q represents a single bond, S, O or NR12; and Y is a group represented by the following general formula (7). z represents an optionally substituted monocyclic or polycyclic aromatic ring. In the formula (6), B represents NR25R26. In the above formulae, R1 to R26 each represents hydrogen, alkyl, alkenyl or alkynyl.
摘要翻译: 旨在提供对HIV病毒感染,风湿病和癌症转移等疾病有效的新型胺化合物。 即,由以下通式(1)表示的胺化合物:在典型情况下,A1和A2各自表示任选取代的单环或多环芳族杂环; W表示环状C 3-10亚烷基,任选取代的单环或多环芳族杂环,单环或多环芳环或部分饱和多环芳环; X表示O,CH 2,C(= O)或NR 11; D为由以下通式(4)或(6)表示的基团。 在式(6)中,Q表示单键,S,O或NR 12; Y为由以下通式(7)表示的基团。 z表示任选取代的单环或多环芳环。 式(6)中,B表示NR25R26。 在上式中,R 1至R 26各自表示氢,烷基,烯基或炔基。
-
公开(公告)号:US20110046113A1
公开(公告)日:2011-02-24
申请号:US12902918
申请日:2010-10-12
申请人: Toru YAMAZAKI , Shigeyuki KIKUMOTO , Masahiro ONO , Atsushi SAITOU , Haruka TAKAHASHI , Sei KUMAKURA , Kunitaka HIROSE , Mikiro YANAKA , Yoshiyuki TAKEMURA , Shigeru SUZUKI , Ryo MATSUI
发明人: Toru YAMAZAKI , Shigeyuki KIKUMOTO , Masahiro ONO , Atsushi SAITOU , Haruka TAKAHASHI , Sei KUMAKURA , Kunitaka HIROSE , Mikiro YANAKA , Yoshiyuki TAKEMURA , Shigeru SUZUKI , Ryo MATSUI
IPC分类号: A61K31/55 , C07D403/12 , C07D401/14 , C07D401/12 , C07D417/12 , C07D403/14 , A61K31/4178 , A61K31/4439 , A61K31/427 , A61K31/454 , A61K31/496 , A61K31/498 , A61K31/5415 , A61K31/5513 , A61P31/18 , A61P31/12 , A61P35/04 , A61P29/00
CPC分类号: C07D233/64 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D417/12 , C07D417/14
摘要: It is intended to provide novel amine compounds which are efficacious against diseases such as infection with HIV virus, rheumatism and cancer metastasis. Namely, amine compounds represented by the following general formula (1): In a typical case, A1 and A2 represent each an optionally substituted monocyclic or polycyclic aromatic heterocycle; W represents cyclic C3-10 alkylene, an optionally substituted monocyclic or polycyclic aromatic heterocycle, a monocyclic or polycyclic aromatic ring or a partly saturated polycyclic aromatic ring; X represents O, CH2, C(═O) or NR11; and D is a group represented by the following general formula (4) or (6). In the formula (6), Q represents a single bond, S, O or NR12; and Y is a group represented by the following general formula (7). —(CR18R19)m3— Or —(CR20R21)m4-z-(CR22R23)m5 (7) z represents an optionally substituted monocyclic or polycyclic aromatic ring. In the formula (6), B represents NR25R26. In the above formulae, R1 to R26 each represents hydrogen, alkyl, alkenyl or alkynyl.
摘要翻译: 旨在提供对HIV病毒感染,风湿病和癌症转移等疾病有效的新型胺化合物。 即,由以下通式(1)表示的胺化合物:在典型情况下,A1和A2各自表示任选取代的单环或多环芳族杂环; W表示环状C 3-10亚烷基,任选取代的单环或多环芳族杂环,单环或多环芳环或部分饱和多环芳环; X表示O,CH 2,C(= O)或NR 11; D为由以下通式(4)或(6)表示的基团。 在式(6)中,Q表示单键,S,O或NR 12; Y为由以下通式(7)表示的基团。 - (CR18R19)m3-或 - (CR20R21)m4-z-(CR22R23)m5(7)z表示任选取代的单环或多环芳环。 式(6)中,B表示NR25R26。 在上式中,R 1至R 26各自表示氢,烷基,烯基或炔基。
-
公开(公告)号:US20070208033A1
公开(公告)日:2007-09-06
申请号:US11704860
申请日:2007-02-09
申请人: Toru Yamazaki , Shigeyuki Kikumoto , Masahiro Ono , Atsushi Saitou , Haruka Takahashi , Sei Kumakura , Kunitaka Hirose , Mikiro Yanaka , Yoshiyuki Takemura , Shigeru Suzuki , Ryo Matsui
发明人: Toru Yamazaki , Shigeyuki Kikumoto , Masahiro Ono , Atsushi Saitou , Haruka Takahashi , Sei Kumakura , Kunitaka Hirose , Mikiro Yanaka , Yoshiyuki Takemura , Shigeru Suzuki , Ryo Matsui
IPC分类号: A61K31/497 , A61K31/4709 , A61K31/4439 , A61K31/433 , A61K31/4196 , A61K31/4184 , A61K31/4178 , C07D403/02
CPC分类号: C07D233/64 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D417/12 , C07D417/14
摘要: It is intended to provide novel amine compounds which are efficacious against diseases such as infection with HIV virus, rheumatism and cancer metastasis. Namely, amine compounds represented by the following general formula (1): In a typical case, A1 and A2 represent each an optionally substituted monocyclic or polycyclic aromatic heterocycle; W represents cyclic C3-10 alkylene, an optionally substituted monocyclic or polycyclic aromatic heterocycle, a monocyclic or polycyclic aromatic ring or a partly saturated polycyclic aromatic ring; X represents O, CH2, C(═O) or NR11; and D is a group represented by the following general formula (4) or (6). In the formula (6), Q represents a single bond, S, O or NR12; and Y is a group represented by the following general formula (7). z represents an optionally substituted monocyclic or polycyclic aromatic ring. In the formula (6), B represents NR25R26. In the above formulae, R1 to R26 each represents hydrogen, alkyl, alkenyl or alkynyl.
摘要翻译: 旨在提供对HIV病毒感染,风湿病和癌症转移等疾病有效的新型胺化合物。 即,由以下通式(1)表示的胺化合物:在典型情况下,A1和A2各自表示任选取代的单环或多环芳族杂环; W表示环状C 3-10亚烷基,任选取代的单环或多环芳族杂环,单环或多环芳环或部分饱和多环芳环; X表示O,CH 2,C(-O)或NR 11; D为由以下通式(4)或(6)表示的基团。 在式(6)中,Q表示单键,S,O或NR 12; Y为由以下通式(7)表示的基团。 z表示任选取代的单环或多环芳环。 式(6)中,B表示NR25R26。 在上式中,R 1至R 26各自表示氢,烷基,烯基或炔基。
-
公开(公告)号:US07176227B2
公开(公告)日:2007-02-13
申请号:US10516158
申请日:2003-09-05
申请人: Toru Yamazaki , Shigeyuki Kikumoto , Masahiro Ono , Atsushi Saitou , Haruka Takahashi , Sei Kumakura , Kunitaka Hirose , Mikiro Yanaka , Yoshiyuki Takemura , Shigeru Suzuki , Ryo Matsui
发明人: Toru Yamazaki , Shigeyuki Kikumoto , Masahiro Ono , Atsushi Saitou , Haruka Takahashi , Sei Kumakura , Kunitaka Hirose , Mikiro Yanaka , Yoshiyuki Takemura , Shigeru Suzuki , Ryo Matsui
IPC分类号: C07D403/12 , A61K314/178
CPC分类号: C07D233/64 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D417/12 , C07D417/14
摘要: Novel amine compounds which are efficacious against diseases such as infection with HIV virus, rheumatism, and cancer metastasis include compounds represented by the following general formula (1), a pharmacologically acceptable salt thereof, or a prodrug thereof: wherein each of n1, n2, and n3 is an integer of 1; each of R1, R2, R3, R4, R5, and R6 is independently a hydrogen atom; A1 is imidazole; A2 is imidazole or imidazole substituted with an alkyl group; W is a phenyl group or naphthyl group; X is CH2; D is a group represented by -Q-Y—B, wherein Q is NR12 and R12 is a hydrogen atom or an alkyl group; Y is (CH2)m3 and m3 is an integer of 2 to 4; and B is N(R25R26), wherein each of R25 and R26 are independently a hydrogen atom, a C1–C6 alkyl group or a C3–C6 cycloalkyl group.
摘要翻译: 对HIV病毒感染,风湿病,癌症转移等有害的新型胺化合物,可以举出以下通式(1)表示的化合物,其药理学上可接受的盐或其前药:其中,n, 1
1,n 2和n 3是1的整数; R 1,R 2,R 3,R 4,R 5,和/或R 3中的每一个 >,并且R 6独立地是氢原子; A 1是咪唑; A 2是被烷基取代的咪唑或咪唑; W是苯基或萘基; X是CH 2 2; D是由-Q-Y-B表示的基团,其中Q是NR 12和R 12是氢原子或烷基; Y为(CH 2 2)m 3,m 3为2〜4的整数, 和B是N(R 25 R 26),其中R 25和R 26各自独立地是 氢原子,C 1 -C 6烷基或C 3 -C 6 -C 6环烷基。 -
公开(公告)号:US20050165063A1
公开(公告)日:2005-07-28
申请号:US10516158
申请日:2003-09-05
申请人: Toru Yamazaki , Shigeyuki Kikumoto , Masahiro Ono , Atsushi Saitou , Haruka Takahashi , Sei Kumakura , Kunitaka Hirose , Mikiro Yanaka , Yoshiyuki Takemura , Shigeru Suzuki , Ryo Matsui
发明人: Toru Yamazaki , Shigeyuki Kikumoto , Masahiro Ono , Atsushi Saitou , Haruka Takahashi , Sei Kumakura , Kunitaka Hirose , Mikiro Yanaka , Yoshiyuki Takemura , Shigeru Suzuki , Ryo Matsui
IPC分类号: A61P19/06 , A61P31/12 , A61P35/04 , C07D233/54 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D417/12 , C07D417/14 , C07D43/02 , A61K31/4172 , A61K31/4439
CPC分类号: C07D233/64 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D417/12 , C07D417/14
摘要: It is intended to provide novel amine compounds which are efficacious against diseases such as infection with HIV virus, rheumatism and cancer metastasis. Namely, amine compounds represented by the following general formula (1): In a typical case, A1 and A2 represent each an optionally substituted monocyclic or polycyclic aromatic heterocycle; W represents cyclic C3-10 alkylene, an optionally substituted monocyclic or polycyclic aromatic heterocycle, a monocyclic or polycyclic aromatic ring or a partly saturated polycyclic aromatic ring; X represents O, CH2, C(═O) or NR11; and D is a group represented by the following general formula (4) or (6). In the formula (6), Q represents a single bond, S, O or NR12; and Y is a group represented by the following general formula (7). z represents an optionally substituted monocyclic or polycyclic aromatic ring. In the formula (6), B represents NR25R26. In the above formulae, R1 to R26 each represents hydrogen, alkyl, alkenyl or alkynyl.
摘要翻译: 旨在提供对HIV病毒感染,风湿病和癌症转移等疾病有效的新型胺化合物。 即,由以下通式(1)表示的胺化合物:在典型情况下,A1和A2各自表示任选取代的单环或多环芳族杂环; W表示环状C 3-10亚烷基,任选取代的单环或多环芳族杂环,单环或多环芳环或部分饱和多环芳环; X表示O,CH 2,C(-O)或NR 11; D为由以下通式(4)或(6)表示的基团。 在式(6)中,Q表示单键,S,O或NR 12; Y为由以下通式(7)表示的基团。 z表示任选取代的单环或多环芳环。 式(6)中,B表示NR25R26。 在上式中,R 1至R 26各自表示氢,烷基,烯基或炔基。
-
-
-
-